EUVIMEDEUVIMED entdecken
Crossref

Burden of depressive and anxiety disorders in China and its provinces, 1990–2021: findings from the Global Burden of Disease Study 2021

Wei Tian iD, Guangcan Yan, Shangzhi Xiong, Jing Zhang, Junyi Peng, Xinyi Zhang, Yuanzhong Zhou, Tao Liu, Yafeng Zhang, Pengpeng Ye, Wenran Zhao, Maoyi Tian

The British Journal of Psychiatry · 2026-01 · 228 (1) · 18-28

DOI: 10.1192/bjp.2024.267 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The British Journal of Psychiatry, online erschienen am 22.01.2025. Verfasst von Wei Tian und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Anxiety Disorders, Depressive Disorder, Cost of Illness, COVID-19. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Depressive and anxiety disorders constitute a major component of the disease burden of mental disorders in China.

Aims

To comprehensively evaluate the disease burden of depressive and anxiety disorders in China.

Method

The raw data is sourced from the Global Burden of Disease, Injuries, and Risk Factors Study (GBD) 2021. This study presented the disease burden by prevalence and disability-adjusted life years (DALYs) of depressive and anxiety disorders at both the national and provincial levels in China from 1990 to 2021, and by gender (referred to as 'sex' in the GBD 2021) and age.

Results

From 1990 to 2021, the number of depressive disorder cases (from 34.4 to 53.1 million) and anxiety disorders (from 40.5 to 53.1 million) increased by 54% (95% uncertainty intervals: 43.9, 65.3) and 31.2% (19.9, 43.8), respectively. The age-standardised prevalence rate of depressive disorders decreased by 6.4% (2.9, 10.4), from 3071.8 to 2875.7 per 100 000 persons, while the prevalence of anxiety disorders remained stable. COVID-19 had a significant adverse impact on both conditions. There was considerable variability in the disease burden across genders, age groups, provinces and temporal trends. DALYs showed similar patterns.

Conclusion

The burden of depressive and anxiety disorders in China has been rising over the past three decades, with a larger increase during COVID-19. There is notable variability in disease burden across genders, age groups and provinces, which are important factors for the government and policymakers when developing intervention strategies. Additionally, the government and health authorities should consider the potential impact of public health emergencies on the burden of depressive and anxiety disorders in future efforts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anxiety DisordersDepressive DisorderCost of IllnessCOVID-19HumansChinaMaleFemaleAdultGlobal Burden of DiseaseMiddle AgedPrevalenceDisability-Adjusted Life YearsYoung AdultAdolescentAgedChild

Stichwörter der Autor:innen

ChinaDepressive and anxiety disordersdisability-adjusted life yearsglobal burden of diseaseprevalence

Autor:innen und Institutionen

  • School of Public Health, Harbin Medical University, Harbin, China.
  • School of Public Health, Zunyi Medical University, Zunyi, China.
  • Department of Cell Biology, School of Basic Medicine, Harbin Medical University, Harbin, China.
  • The George Institute for Global Health, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.
  • Department of Chronic Non-Communicable Diseases, Guizhou Centre for Disease Control and Prevention, Guiyang, China.
  • Institute for Hospital Management of Henan Province, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

ORCID-Profile: Wei Tian

Zitieren

APA

Tian, W., Yan, G., Xiong, S., Zhang, J., Peng, J., Zhang, X., Zhou, Y., Liu, T., Zhang, Y., Ye, P., Zhao, W., & Tian, M. (2026). Burden of depressive and anxiety disorders in China and its provinces, 1990–2021: findings from the Global Burden of Disease Study 2021. The British Journal of Psychiatry, 228(1), 18-28. https://doi.org/10.1192/bjp.2024.267

Vancouver

Tian W, Yan G, Xiong S, Zhang J, Peng J, Zhang X, et al. Burden of depressive and anxiety disorders in China and its provinces, 1990–2021: findings from the Global Burden of Disease Study 2021. The British Journal of Psychiatry. 2026;228(1):18-28. doi:10.1192/bjp.2024.267

BibTeX
@article{Tian2026,
  author = {Tian, Wei and Yan, Guangcan and Xiong, Shangzhi and Zhang, Jing and Peng, Junyi and Zhang, Xinyi and Zhou, Yuanzhong and Liu, Tao and Zhang, Yafeng and Ye, Pengpeng and Zhao, Wenran and Tian, Maoyi},
  title = {Burden of depressive and anxiety disorders in China and its provinces, 1990–2021: findings from the Global Burden of Disease Study 2021},
  journal = {The British Journal of Psychiatry},
  year = {2026},
  volume = {228},
  number = {1},
  pages = {18--28},
  doi = {10.1192/bjp.2024.267}
}
Kostenlos starten →